화이자(PFE)는 NYSE에 상장된 Healthcare · Drug Manufacturers - General 기업입니다. 현재가 $27.66 (+0.07%), 시가총액 $147.90B, PER (주가수익비율) 19.81, 52주 최저~최고 $23.12 ~ $28.55.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeu
화이자의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
화이자의 현재 주가는 $27.66 (+0.07%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
화이자의 시가총액은 약 $147.90B입니다. PER은 19.81입니다.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and P